Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
A database of clinical trials and their results from Australia, New Zealand, and other countries.
account_circle
Log in
to register or update your trial
search
Search for trials
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12625000996460
Ethics application status
Approved
Date submitted
14/08/2025
Date registered
9/09/2025
Date last updated
9/09/2025
Date data sharing statement initially provided
9/09/2025
Type of registration
Retrospectively registered
Titles & IDs
Public title
The addition of computer aided detection to texture and colour enhancement imaging (TXI) for adenoma detection during colonoscopy: have we reached a glass ceiling?
Query!
Scientific title
Adenoma detection during colonoscopy: have we reached a glass ceiling? The impact of the addition of computer aided detection to texture and colour enhancement imaging in adult patients undergoing colonoscopy
Query!
Secondary ID [1]
315135
0
None
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Colon polyps
338558
0
Query!
Condition category
Condition code
Oral and Gastrointestinal
334863
334863
0
0
Query!
Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
The use of texture and colour enhancement imaging (TXI) - a form of advanced endoscopic imaging technology, in combination with artificial intelligence for the detection of colonic polyps. TXI is a 'push-button' technology included with Olympus endoscopy systems which will be set in use for the entire colonoscope withdrawal. Artificial intelligence (computer aided detection) is an additional system that can be added to the Olympus endoscopy system, which uses artificial intelligence to identify and highlight colonic polyps. The anticipated time of colonoscopy is approximately 20 minutes, with AI processing occurring in real time. The procedures will be performed by consultant gastroenterologists in both the intervention and control groups. The computer aided detection images will be incorporated into a single colonoscopy report completed by the gastroenterologist. The intervention will be delivered once at the time of colonoscopy and includes only the index colonoscopy. This will be performed at two tertiary centres in South Australia. Patients are not required to adhere to the intervention. All proceduralists are involved as associate investigators and aware of the trial protocol. The principal investigator will be providing oversight to ensure adherence.
Query!
Intervention code [1]
331758
0
Early detection / Screening
Query!
Comparator / control treatment
Historical control group - this includes patients from a previous randomised controlled trial conducted under the same conditions, in the same location, with the same inclusion and exclusion criteria (ACTRN12621000708853). The historical control group will consist of the 'TXI' or intervention arm from our previous randomised controlled trial. This data was collected between 2021-2023. The data points included in this study are the same data points that were collected for the historical controls.
Query!
Control group
Historical
Query!
Outcomes
Primary outcome [1]
342491
0
Adenomas detected per colonoscopy
Query!
Assessment method [1]
342491
0
Numerical number of adenomas per colonoscopy - this will be determined from pathology records and well as colonoscopy reports.
Query!
Timepoint [1]
342491
0
At the time of index colonoscopy
Query!
Secondary outcome [1]
451029
0
Adenoma detection rate
Query!
Assessment method [1]
451029
0
Numerical adenoma detection rate - again this will be determined from pathology records and colonoscopy reports
Query!
Timepoint [1]
451029
0
At index colonoscopy
Query!
Secondary outcome [2]
451030
0
Colonoscope withdrawal time
Query!
Assessment method [2]
451030
0
All procedures will be timed using a stopwatch that will be paused at the time of polyp resection and restart when colonoscope withdrawal recommences. This is the exact same method that was used to determine the withdrawal time for the historical data and these procedure times can be extracted from the previous trial database.
Query!
Timepoint [2]
451030
0
At index colonoscopy
Query!
Secondary outcome [3]
451031
0
Non-neoplastic polyps resected per colonoscopy
Query!
Assessment method [3]
451031
0
Numerical - again this will be determined from pathology records and colonoscopy reports
Query!
Timepoint [3]
451031
0
At index colonoscopy
Query!
Eligibility
Key inclusion criteria
All patients presenting for colonoscopy at the Lyell McEwin Hospital or Modbury Hospital
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
85
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
Coagulation disorders
Significant comorbidity (severe heart failure, chronic kidney disease or chronic obstructive pulmonary disease)
Pregnancy
Personal history of inflammatory bowel disease
Family history of polyposis or non-polyposis bowel cancer syndromes
Query!
Study design
Purpose of the study
Diagnosis
Query!
Allocation to intervention
Non-randomised trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Other
Query!
Other design features
This is a prospective non-randomised trial where the intervention group will be compared to a historical control group (ACTRN12621000708853).
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Completed
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
3/06/2024
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
15/05/2025
Query!
Date of last data collection
Anticipated
Query!
Actual
22/08/2025
Query!
Sample size
Target
100
Query!
Accrual to date
Query!
Final
100
Query!
Recruitment in Australia
Recruitment state(s)
SA
Query!
Funding & Sponsors
Funding source category [1]
319712
0
Self funded/Unfunded
Query!
Name [1]
319712
0
Query!
Address [1]
319712
0
Query!
Country [1]
319712
0
Query!
Primary sponsor type
University
Query!
Name
Adelaide University
Query!
Address
Query!
Country
Australia
Query!
Secondary sponsor category [1]
322220
0
None
Query!
Name [1]
322220
0
Query!
Address [1]
322220
0
Query!
Country [1]
322220
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
318265
0
Central Adelaide Local Health Network HREC
Query!
Ethics committee address [1]
318265
0
https://www.rah.sa.gov.au/research/for-researchers/central-adelaide-local-health-network-human-research-ethics-committee
Query!
Ethics committee country [1]
318265
0
Australia
Query!
Date submitted for ethics approval [1]
318265
0
07/03/2024
Query!
Approval date [1]
318265
0
16/05/2024
Query!
Ethics approval number [1]
318265
0
19246
Query!
Summary
Brief summary
This study aims to determine whether the use of artificial intelligence for polyp detection during colonoscopy has additional benefit when used in combination with texture and colour enhancement imaging (TXI) - a new form of advanced endoscopic imaging technology. In our previous study comparing TXI to usual endoscopic imaging we demonstrated significant improvement in polyp detection with TXI (ACTRN12621000708853). Artificial intelligence has been shown in clinical trials to improve polyp detection. We are aiming to assess whether there is a glass ceiling on polyp detection where additional technology may not be of incremental benefit.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
143634
0
Dr Edward Young
Query!
Address
143634
0
Lyell McEwin Hospital, Department of Gastroenterology. Haydown Road, Elizabeth Vale, SA 5112
Query!
Country
143634
0
Australia
Query!
Phone
143634
0
+61 8 82821897
Query!
Fax
143634
0
Query!
Email
143634
0
[email protected]
Query!
Contact person for public queries
Name
143635
0
Edward Young
Query!
Address
143635
0
Lyell McEwin Hospital, Department of Gastroenterology. Haydown Road, Elizabeth Vale, SA 5112
Query!
Country
143635
0
Australia
Query!
Phone
143635
0
+61 881829000
Query!
Fax
143635
0
Query!
Email
143635
0
[email protected]
Query!
Contact person for scientific queries
Name
143636
0
Edward Young
Query!
Address
143636
0
Lyell McEwin Hospital, Department of Gastroenterology. Haydown Road, Elizabeth Vale, SA 5112
Query!
Country
143636
0
Australia
Query!
Phone
143636
0
+61 881829000
Query!
Fax
143636
0
Query!
Email
143636
0
[email protected]
Query!
Data sharing statement
Will the study consider sharing individual participant data?
Yes
Will there be any conditions when requesting access to individual participant data?
Persons/groups eligible to request access:
•
Researchers
Conditions for requesting access:
•
Yes, conditions apply:
•
Requires review on a case-by-case basis by the trial custodian, sponsor or data sharing committee
•
Requires a scientifically sound proposal or protocol
What individual participant data might be shared?
•
De-identified individual participant data:
•
All outcomes data
•
Published results
•
Primary outcome(s)
•
Safety data
What types of analyses could be done with individual participant data?
•
Any type of analysis (i.e. no restrictions on data re-use)
When can requests for individual participant data be made (start and end dates)?
From:
At the end of the study
To:
No end date
Where can requests to access individual participant data be made, or data be obtained directly?
•
Email of trial custodian, sponsor or committee:
[email protected]
Are there extra considerations when requesting access to individual participant data?
No
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF